Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-119792
Filing Date
2024-11-01
Accepted
2024-11-01 06:08:53
Documents
73
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bdsx-20240930.htm   iXBRL 10-Q 2127382
2 EX-10.1 bdsx-ex10_1.htm EX-10.1 55013
3 EX-31.1 bdsx-ex31_1.htm EX-31.1 14949
4 EX-31.2 bdsx-ex31_2.htm EX-31.2 14967
5 EX-32.1 bdsx-ex32_1.htm EX-32.1 7637
6 EX-32.2 bdsx-ex32_2.htm EX-32.2 7862
  Complete submission text file 0000950170-24-119792.txt   10005419

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bdsx-20240930.xsd EX-101.SCH 1786432
76 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20240930_htm.xml XML 1546600
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39659 | Film No.: 241416844
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)